Close menu

July 26th, 2022 | 13:05 CEST

Crash stocks: BASF, Meta Materials, Uniper, Nordex - Will there be a comeback like Tesla?

  • Technology
  • chemicals
  • Investments
Photo credits:

In stock market corrections that come from the interest rate and inflation side, when the relationship between inflation and capital market returns normalizes is critical. In the long NASDAQ upswing from 2019 to 2021, valuations doubled as future cash flows were extrapolated down to present value with minimal interest rates. That let potential market caps explode, and leveraged positions could also be taken at virtually no cost. Currently, the market is showing a different side. Negative real interest rates, high refinancing costs and increased margin calls are weighing on investors' minds. Some stocks experienced a real crash - will they bounce back soon like Tesla?

time to read: 5 minutes | Author: André Will-Laudien
ISIN: BASF SE NA O.N. | DE000BASF111 , Meta Materials Inc. | US59134N1046 , UNIPER SE NA O.N. | DE000UNSE018 , NORDEX SE O.N. | DE000A0D6554

Table of contents:

    BASF - 10% away from the low

    Things will get really exciting this week at Europe's largest chemical group. That is because the Board of Executive Directors will answer questions on Wednesday about the figures for the second quarter. Ludwigshafen-based chemical giant BASF is one of the largest gas consumers in Germany, but so far, there have been no supply restrictions. Nevertheless, CEO Martin Brudermüller will have to elaborate on the threat of supply shortages and their impact on production. Shareholders are very unsettled after a 45% drop in the share price in 2022; even the recent recovery movement in the DAX has only been enough for a 10% increase.

    The Ludwigshafen-based Company had already published surprisingly good key data in advance but did not comment in more detail on the full-year forecast. Three weeks ago, the DAX-listed group maintained its forecast for fiscal 2022. Accordingly, sales will amount to between EUR 74 billion and EUR 77 billion, and EBIT before special items could land between EUR 6.6 billion and EUR 7.2 billion, according to management estimates. More detailed information should be available on Wednesday. Analysts expect earnings per share of EUR 1.94 on average, which is a decline of around 5% compared with the first quarter of 2021.

    The share is currently in a waiting position but is well supported in the zone at EUR 41 to EUR 45. Those who consider the long-term chart favourable now should buy the first pieces and add a stop at EUR 38.70. However, investors should keep the gas issue on the radar, just as there is also the threat of a small dividend cut in the coming year due to falling profits. More background information is also available in a brand new report on BASF by

    Meta Materials - Large capital increase at low prices

    In days of energy scarcity and increased industrial efficiencies, the focus is again on technology companies that make more efficient processes possible through their patents. Whereas a few years ago it was chic to build everything much lighter and more durable, today it is energy efficiency and independence from petrochemicals that counts.

    At the technology forge Meta Materials, everything revolves around coatings on glass, building structures and other elements. Sensibly installed antennas and invisible cloaks for defense systems have also been on the solutions catalog for some time. Now the specialist for coatings and future-oriented materials also wants to move into the field of e-mobility.

    With its partner company Coulometrics, Meta now wants to make batteries for e-cars safer, more durable and more powerful. In this industry, in particular, the still low performance of the units means that there is a need for disruptive technologies capable of delivering new ways of thinking and changing industries for the long term. Tesla has been conducting intensive research in this area for years but so far has not made any significant progress beyond the common Li-ion battery. The requirements are going in the right direction of longer service life and recyclability.

    META®-Materials' developments can be divided into three areas: holography, lithography and wireless sensor technology with strong IT networking and artificial intelligence implementation. "With the recent strategic acquisitions of Plasma App and Optodot, combined with our roll-to-roll thin film deposition manufacturing facility in Quebec, we now have the capability to make Li-ion batteries safer and more efficient," said George Palikaras, president and CEO of META.

    In late June, the Company replenished its coffers substantially. In a direct placement offering, it raised a gross amount of about USD 50 million through the sale of 37.037 million shares and warrants. In the current stormy times, this is clear evidence of investor confidence in the future market position of META®-Materials. Although the Company is constantly reporting good progress, it was hit hard in the last NASDAQ sell-off, currently down to USD 0.95. On August 9, the Q2 figures will be released after hours, and the following day there will be a webcast, so there may be some positive surprises. Position yourself in time for the upward turn.

    Uniper and Nordex - Eyes closed and hope for the best?

    At this point, we always report regularly on potential turnaround candidates. However, the following stocks have crashed and are stuck at the bottom for the time being.

    In the case of Nordex, the ongoing capital increases, which always mean additional financing for the long-term investor if they want to hold on to their share, are a burden. The major shareholder Acciona, however, has always correctly followed suit, yet the frequency is unsettling. After all, the GreenTech stock was still 100% higher at the beginning of the year. It takes a lot of imagination to get back there in the short term because Nordex recently reported that it is unlikely to achieve a positive margin in 2022, although the order books are full. On August 11, 2022, there are figures for the 2nd quarter, which should be very exciting. Wait for the report!

    At Uniper, the government bailout finally happened. From June 14 to September 30, the economic deficit is expected to amount to EUR 6.2 billion, Uniper CEO Klaus-Dieter Maubach said last Friday. The assumption is based, among other things, on current market prices and could also change. The federal government will probably step in with EUR 15 billion, of which EUR 8 billion could flow as pure equity. After the transaction, however, Berlin will have a stake of more than 30%. As a precondition, Uniper also assures the state that it will limit salaries for the group's management board and no longer pay dividends to shareholders. Consumers also have a stake in the bailout, as starting in October, all gas consumers will pay a levy to cover the dramatic increase in gas procurement costs in Germany. The share lost almost 50% of its value in just 3 days and was downgraded significantly. Until a new valuation basis is found, we advise caution.

    The downward corrections are not over yet. Even if the markets are capable of temporary recoveries, downward pressure remains in anticipation of higher interest rates, inflation and poorer economic development. BASF, Nordex and Uniper are examples of so-called "Fallen Angels", here we should wait a little longer. At Meta Materials, a positive surprise could lurk in the upcoming figures.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") currently hold or hold shares or other financial instruments of the aforementioned companies and speculate on their price developments. In this respect, they intend to sell or acquire shares or other financial instruments of the companies (hereinafter each referred to as a "Transaction"). Transactions may thereby influence the respective price of the shares or other financial instruments of the Company.
    In this respect, there is a concrete conflict of interest in the reporting on the companies.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.
    For this reason, there is also a concrete conflict of interest.
    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    André Will-Laudien

    Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets.

    About the author

    Related comments:

    Commented by Juliane Zielonka on September 29th, 2023 | 07:00 CEST

    Defence Therapeutics, Schott Pharma, Allianz Group: Focus on Innovation, Growth and Portfolio Optimization

    • Biotechnology
    • Pharma
    • Investments

    According to a recent study, biotech company Defence Therapeutics achieves twice the immune response of conventional mRNA therapies with its Accum® mRNA technology. That translates to fewer side effects and a more effective treatment. According to Precedence Research, the market size for mRNA therapeutics is projected to reach approximately USD 137.59 billion by 2032. It is expected to grow at a CAGR of 13.2% from 2023 to 2032. In order to inject these active ingredients, precision-fit medical vials are required, and Schott Pharma is ensuring this with their IPO launched on the German stock exchange this week, which could bring a valuation of around EUR 4 billion. The Allianz Group, on the other hand, is focusing on consolidation, selling its business in the Middle East and thus flushing around EUR 210 million cash into its coffers.


    Commented by André Will-Laudien on September 28th, 2023 | 08:05 CEST

    Attention: Extended correction - Buy the right stocks now! Bayer, Viva Gold, TUI, and BASF are on the list!

    • Mining
    • Gold
    • Pharma
    • chemicals
    • travel

    Higher inflation and rising interest rates - this connection should be clear to investors. The interest rate level in Germany has moved from negative territory to 2.77% in the 10-year range, but stocks continued to rise cheerfully. The party led to all-time highs of 16,528 points in July, but the fundamental situation of the companies deteriorated in parallel. Only after repeated warnings from the US Federal Reserve did the explosive NASDAQ also enter a correction. And it continues. Yesterday, the CEO of US investment bank JPMorgan, Dimon, warned that the world may not be prepared for 7% capital market interest rates. He and Dr. Jens Erhardt, the CEO of the asset management company DJE, warn of stronger setbacks on the stock markets. Some stocks have already undergone a strong correction. Here is a brief overview.


    Commented by Armin Schulz on September 27th, 2023 | 09:05 CEST

    Nikola, Saturn Oil + Gas, BASF - A Buy in difficult times?

    • Mining
    • Oil
    • Batteries
    • renewableenergies
    • chemicals

    These are challenging times on the stock market. Central banks have not announced the end of interest rate hikes, which is poison for growth companies. In addition, extreme weather conditions are affecting the production of some companies, and there are geopolitical tensions to consider, including the ongoing Ukraine conflict and the simmering dispute between the US and China. Recently, there have also been tensions between China and Germany. Following critical statements by Foreign Minister Baerbock to China's Xi Jinping, the German ambassador was summoned. Energy shortages are becoming increasingly significant for many companies in Germany. Today, we look at three companies suffering from the problems described.